These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 1655338

  • 1. Additive antiproteinuric effect of angiotensin-converting enzyme inhibition and non-steroidal anti-inflammatory drug therapy: a clue to the mechanism of action.
    Heeg JE, de Jong PE, de Zeeuw D.
    Clin Sci (Lond); 1991 Sep; 81(3):367-72. PubMed ID: 1655338
    [Abstract] [Full Text] [Related]

  • 2. Additive antiproteinuric effect of the NSAID indomethacin and the ACE inhibitor lisinopril.
    Heeg JE, de Jong PE, Vriesendorp R, de Zeeuw D.
    Am J Nephrol; 1990 Sep; 10 Suppl 1():94-7. PubMed ID: 2175149
    [Abstract] [Full Text] [Related]

  • 3. Reduction of proteinuria by angiotensin converting enzyme inhibition.
    Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D.
    Kidney Int; 1987 Jul; 32(1):78-83. PubMed ID: 3041097
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.
    Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D.
    Kidney Int; 1989 Aug; 36(2):272-9. PubMed ID: 2550696
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mechanism of the antiproteinuric effect of angiotensin-converting enzyme inhibition.
    de Zeeuw D, Heeg JE, Stelwagen T, de Jong RJ, de Jong PE.
    Contrib Nephrol; 1990 Aug; 83():160-5. PubMed ID: 1966072
    [No Abstract] [Full Text] [Related]

  • 8. Renal effects of captopril, indomethacin and nifedipine in nephrotic patients after an oral protein load.
    Garini G, Mazzi A, Buzio C, Mutti A, Allegri L, Savazzi G, Borghetti A.
    Nephrol Dial Transplant; 1996 Apr; 11(4):628-34. PubMed ID: 8671850
    [Abstract] [Full Text] [Related]

  • 9. Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathy.
    Bos H, Andersen S, Rossing P, De Zeeuw D, Parving HH, De Jong PE, Navis G.
    Kidney Int Suppl; 2000 Apr; 75():S32-7. PubMed ID: 10828759
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
    Tylicki L, Rutkowski P, Renke M, Rutkowski B.
    Am J Nephrol; 2002 Apr; 22(4):356-62. PubMed ID: 12169868
    [Abstract] [Full Text] [Related]

  • 12. Effect of lisinopril monotherapy on renal hemodynamics.
    Reams GP, Bauer JH.
    Am J Kidney Dis; 1988 Jun; 11(6):499-507. PubMed ID: 2837083
    [Abstract] [Full Text] [Related]

  • 13. Add-on angiotensin receptor blockade with maximized ACE inhibition.
    Agarwal R.
    Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
    [Abstract] [Full Text] [Related]

  • 14. Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients.
    Vogt L, de Zeeuw D, Woittiez AJ, Navis G.
    Nephrol Dial Transplant; 2009 Apr; 24(4):1182-9. PubMed ID: 19037084
    [Abstract] [Full Text] [Related]

  • 15. Effect of increasing doses of lisinopril on proteinuria of normotensive patients with IgA nephropathy and normal renal function.
    Palla R, Panichi V, Finato V, Parrini M, Andreini B, Bianchi AM, Giovannini L, Migliori M, Bertelli AA.
    Int J Clin Pharmacol Res; 1994 Apr; 14(1):35-43. PubMed ID: 7927959
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of high dose ramipril with or without indomethacin on glomerular selectivity.
    Pisoni R, Ruggenenti P, Sangalli F, Lepre MS, Remuzzi A, Remuzzi G.
    Kidney Int; 2002 Sep; 62(3):1010-9. PubMed ID: 12164885
    [Abstract] [Full Text] [Related]

  • 18. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
    Zoja C, Donadelli R, Corna D, Testa D, Facchinetti D, Maffi R, Luzzana E, Colosio V, Bertani T, Remuzzi G.
    Am J Kidney Dis; 1997 Feb; 29(2):254-64. PubMed ID: 9016898
    [Abstract] [Full Text] [Related]

  • 19. Symptomatic antiproteinuric treatment decreases serum lipoprotein (a) concentration in patients with glomerular proteinuria.
    Gansevoort RT, Heeg JE, Dikkeschei FD, de Zeeuw D, de Jong PE, Dullaart RP.
    Nephrol Dial Transplant; 1994 Feb; 9(3):244-50. PubMed ID: 8052429
    [Abstract] [Full Text] [Related]

  • 20. Hemodynamic responses to converting enzyme inhibition in patients with renal disease.
    August P, Cody RJ, Sealey JE, Laragh JH.
    Am J Hypertens; 1989 Aug; 2(8):599-603. PubMed ID: 2550029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.